{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:36:02Z","timestamp":1776479762492,"version":"3.51.2"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences & health services","doi-asserted-by":"crossref","award":["40713-192-03-97"],"award-info":[{"award-number":["40713-192-03-97"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-022-00451-x","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T15:02:50Z","timestamp":1663858970000},"page":"427-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of vitamins C and E on cancer survival; a systematic review"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0694-7495","authenticated-orcid":false,"given":"Shahrzad","family":"Mohseni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-9721","authenticated-orcid":false,"given":"Ozra","family":"Tabatabaei-Malazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-4915","authenticated-orcid":false,"given":"Hanieh-Sadat","family":"Ejtahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9465-7588","authenticated-orcid":false,"given":"Mostafa","family":"Qorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-6818","authenticated-orcid":false,"given":"Leila","family":"Azadbakht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7525-8418","authenticated-orcid":false,"given":"Patricia","family":"Khashayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-7597","authenticated-orcid":false,"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"451_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"451_CR2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/01635581.2020.1795692","volume":"73","author":"B Abiri","year":"2021","unstructured":"Abiri B, Vafa M, Vitamin C, Cancer. The role of vitamin C in disease progression and quality of life in cancer patients. Nutr Cancer. 2021;73:1282\u201392.","journal-title":"Nutr Cancer"},{"key":"451_CR3","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/nu12082338","volume":"12","author":"HR Morrin","year":"2020","unstructured":"Morrin HR, Pullar JM, Spencer E, Vissers MCM, Robinson BA, Dachs GU. Low vitamin C status in patients with cancer is associated with patient and tumor characteristics. Nutrients. 2020;12:2338. https:\/\/doi.org\/10.3390\/nu12082338.","journal-title":"Nutrients"},{"key":"451_CR4","doi-asserted-by":"publisher","first-page":"13604","DOI":"10.1073\/pnas.0506390102","volume":"102","author":"Q Chen","year":"2005","unstructured":"Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102:13604\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"451_CR5","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1073\/pnas.0702854104","volume":"104","author":"Q Chen","year":"2007","unstructured":"Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A. 2007;104:8749\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"451_CR6","doi-asserted-by":"publisher","first-page":"110588","DOI":"10.1016\/j.biopha.2020.110588","volume":"131","author":"J Fu","year":"2020","unstructured":"Fu J, Wu Z, Liu J, Wu T, Vitamin C. A stem cell promoter in cancer metastasis and immunotherapy. Biomed Pharmacother. 2020;131:110588. https:\/\/doi.org\/10.1016\/j.biopha.2020.110588.","journal-title":"Biomed Pharmacother"},{"key":"451_CR7","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.7314\/APJCP.2013.14.6.3663","volume":"14","author":"WA Mehdi","year":"2013","unstructured":"Mehdi WA, Zainulabdeen JA, Mehde AA. Investigation of the antioxidant status in multiple myeloma patients: effects of therapy. Asian Pac J Cancer Prev. 2013;14:3663\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"451_CR8","first-page":"983","volume":"25","author":"C Vollbracht","year":"2011","unstructured":"Vollbracht C, Schneider B, Leendert V, Weiss G, Auerbach L, Beuth J. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-\/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo. 2011;25:983\u201390.","journal-title":"In Vivo"},{"key":"451_CR9","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.3390\/ijms21218397","volume":"21","author":"M Codini","year":"2020","unstructured":"Codini M. Why Vitamin C could be an excellent complementary remedy to conventional therapies for breast cancer. Int J Mol Sci. 2020;21:8397. https:\/\/doi.org\/10.3390\/ijms21218397.","journal-title":"Int J Mol Sci"},{"key":"451_CR10","doi-asserted-by":"publisher","unstructured":"Li P, Han B, Jia H, Mo S, Deng K, Huang Y, et al. High-dose vitamin C tends to kill colorectal cancer with high MALAT1 expression. J Oncol. 2020; 2020:2621308.\u00a0https:\/\/doi.org\/10.1155\/2020\/2621308.","DOI":"10.1155\/2020\/2621308"},{"key":"451_CR11","doi-asserted-by":"publisher","first-page":"18415","DOI":"10.18632\/aging.103769","volume":"12","author":"D Zhang","year":"2020","unstructured":"Zhang D, Xu P, Li Y, Wei B, Yang S, Zheng Y, et al. Association of vitamin C intake with breast cancer risk and mortality: a meta-analysis of observational studies. Aging. 2020;12:18415\u201335.","journal-title":"Aging"},{"key":"451_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fphar.2020.00211","volume":"11","author":"FJ Roa","year":"2020","unstructured":"Roa FJ, Pe\u00f1a E, Gatica M, Escobar-Acu\u00f1a K, Saavedra P, Maldonado M, et al. Therapeutic use of vitamin C in cancer: physiological considerations. Front Pharmacol. 2020;11:211. https:\/\/doi.org\/10.3389\/fphar.2020.00211.","journal-title":"Front Pharmacol"},{"key":"451_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/nu13030735","volume":"13","author":"A Zasowska-Nowak","year":"2021","unstructured":"Zasowska-Nowak A, Nowak PJ, Cia\u0142kowska-Rysz A. High-dose vitamin C in advanced-stage cancer patients. Nutrients. 2021;13:735. https:\/\/doi.org\/10.3390\/nu13030735.","journal-title":"Nutrients"},{"key":"451_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12885-020-06947-6","volume":"20","author":"C Moore","year":"2020","unstructured":"Moore C, Palau VE, Mahboob R, Lightner J, Stone W, Krishnan K. Upregulation of pERK and c-JUN by \u03b3-tocotrienol and not \u03b1-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells. BMC Cancer. 2020;20:428. https:\/\/doi.org\/10.1186\/s12885-020-06947-6.","journal-title":"BMC Cancer"},{"key":"451_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/antiox9010051","volume":"9","author":"D Figueroa Gonzalez","year":"2020","unstructured":"Figueroa Gonzalez D, Young F. Gamma tocopherol reduced chemotherapeutic-induced ROS in an ovarian granulosa cell line, but not in breast cancer cell lines in vitro. Antioxid (Basel). 2020;9:51. https:\/\/doi.org\/10.3390\/antiox9010051.","journal-title":"Antioxid (Basel)"},{"key":"451_CR16","first-page":"2060","volume":"41","author":"CW Wei","year":"2019","unstructured":"Wei CW, Yu YL, Chen YH, Hung YT, Yiang GT. Anticancer effects of methotrexate in combination with \u03b1\u2013tocopherol and \u03b1\u2013tocopherol succinate on triple\u2013negative breast cancer. Oncol Rep. 2019;41:2060\u20136.","journal-title":"Oncol Rep"},{"key":"451_CR17","doi-asserted-by":"publisher","first-page":"105835","DOI":"10.1016\/j.jsbmb.2021.105835","volume":"209","author":"Y Ding","year":"2021","unstructured":"Ding Y, Fan J, Fan Z, Zhang K. \u03b3-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the \u03b3-Tocotrienol-NF-\u03baB-P-gp axis. J Steroid Biochem Mol Biol. 2021;209:105835. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105835.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"451_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2015.12.003","volume":"162","author":"HY Peh","year":"2016","unstructured":"Peh HY, Tan WS, Liao W, Wong WS. Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Ther. 2016;162:152\u201369.","journal-title":"Pharmacol Ther"},{"key":"451_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.ejca.2014.02.013","volume":"50","author":"HR Harris","year":"2014","unstructured":"Harris HR, Orsini N, Wolk A. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer. 2014;50:1223\u201331.","journal-title":"Eur J Cancer"},{"key":"451_CR20","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/09637486.2016.1197892","volume":"67","author":"J Chen","year":"2016","unstructured":"Chen J, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis. Int J Food Sci Nutr. 2016;67:744\u201353.","journal-title":"Int J Food Sci Nutr"},{"key":"451_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/1534735414534463","volume":"13","author":"H Fritz","year":"2014","unstructured":"Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al. Intravenous vitamin C and cancer: a systematic review. Integr Cancer Ther. 2014;13:280\u2013300.","journal-title":"Integr Cancer Ther"},{"key":"451_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/antiox7070089","volume":"7","author":"G Nauman","year":"2018","unstructured":"Nauman G, Gray JC, Parkinson R, Levine M, Paller CJ. Systematic review of intravenous ascorbate in cancer clinical trials. Antioxid (Basel). 2018;7:89. https:\/\/doi.org\/10.3390\/antiox7070089.","journal-title":"Antioxid (Basel)"},{"key":"451_CR23","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/nu11050977","volume":"11","author":"GNY van Gorkom","year":"2019","unstructured":"van Gorkom GNY, Lookermans EL, Van Elssen CHMJ, Bos GMJ. The Effect of Vitamin C (Ascorbic Acid) in the treatment of patients with cancer: a systematic review. Nutrients. 2019;11:977. https:\/\/doi.org\/10.3390\/nu11050977.","journal-title":"Nutrients"},{"key":"451_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1634\/theoncologist.2014-0381","volume":"20","author":"C Jacobs","year":"2015","unstructured":"Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? a systematic review. Oncologist. 2015;20:210\u201323.","journal-title":"Oncologist"},{"key":"451_CR25","first-page":"409","volume":"27","author":"A Alkhenizan","year":"2007","unstructured":"Alkhenizan A, Hafez K. The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Ann Saudi Med. 2007;27:409\u201314.","journal-title":"Ann Saudi Med"},{"key":"451_CR26","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"451_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1\u201312. https:\/\/doi.org\/10.1016\/0197-2456(95)00134-4.","journal-title":"Control Clin Trials"},{"key":"451_CR28","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ"},{"key":"451_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jare.2020.03.004","volume":"24","author":"J Ou","year":"2020","unstructured":"Ou J, Zhu X, Chen P, Du Y, Lu Y, Peng X, et al. A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer. J Adv Res. 2020;24:175\u201382. https:\/\/doi.org\/10.1016\/j.jare.2020.03.004.","journal-title":"J Adv Res"},{"key":"451_CR30","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1158\/1078-0432.CCR-19-0594","volume":"25","author":"BG Allen","year":"2019","unstructured":"Allen BG, Bodeker KL, Smith MC, Monga V, Sandhu S, Hohl R, et al. First-in-human phase i clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma. Clin Cancer Res. 2019;25:6590\u20137.","journal-title":"Clin Cancer Res"},{"key":"451_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.31989\/ffhd.v9i3.590","volume":"9","author":"N Mikirova","year":"2019","unstructured":"Mikirova N, Casciari J, Hunninghake R. Continuous intravenous vitamin C in the cancer treatment: re-evaluation of a Phase I clinical study. FFHD. 2019;9:180\u2013204.","journal-title":"FFHD"},{"key":"451_CR32","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12885-019-5696-z","volume":"19","author":"F Wang","year":"2019","unstructured":"Wang F, He MM, Wang ZX, Li S, Jin Y, Ren C, et al. Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer. BMC Cancer. 2019;19:460. https:\/\/doi.org\/10.1186\/s12885-019-5696-z.","journal-title":"BMC Cancer"},{"key":"451_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2017.12.009","volume":"66","author":"H Zhao","year":"2018","unstructured":"Zhao H, Zhu H, Huang J, Zhu Y, Hong M, Zhu H, et al. The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leuk Res. 2018;66:1\u20137.","journal-title":"Leuk Res"},{"key":"451_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.21037\/tau.2017.04.42","volume":"6","author":"TK Nielsen","year":"2017","unstructured":"Nielsen TK, H\u00f8jgaard M, Andersen JT, J\u00f8rgensen NR, Zerahn B, Kristensen B, et al. Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial. Transl Androl Urol. 2017;6:517\u201328.","journal-title":"Transl Androl Urol"},{"key":"451_CR35","doi-asserted-by":"publisher","first-page":"17188","DOI":"10.1038\/s41598-017-17568-8","volume":"7","author":"K Polireddy","year":"2017","unstructured":"Polireddy K, Dong R, Reed G, Yu J, Chen P, Williamson S, et al. High dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: mechanisms and a phase I\/IIa study. Sci Rep. 2017;7:17188. https:\/\/doi.org\/10.1038\/s41598-017-17568-8.","journal-title":"Sci Rep"},{"key":"451_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","volume":"31","author":"JD Schoenfeld","year":"2017","unstructured":"Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, et al. O2\u22c5- and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. 2017;31:487-500.e8.","journal-title":"Cancer Cell"},{"key":"451_CR37","doi-asserted-by":"publisher","first-page":"e0120228","DOI":"10.1371\/journal.pone.0120228","volume":"10","author":"LJ Hoffer","year":"2015","unstructured":"Hoffer LJ, Robitaille L, Zakarian R, Melnychuk D, Kavan P, Agulnik J, et al. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial. PLoS One. 2015;10:e0120228. https:\/\/doi.org\/10.1371\/journal.pone.0120228.","journal-title":"PLoS ONE"},{"key":"451_CR38","first-page":"111","volume":"39","author":"H Kawada","year":"2014","unstructured":"Kawada H, Sawanobori M, Tsuma-Kaneko M, Wasada I, Miyamoto M, Murayama H, et al. Phase I clinical trial of intravenous L-ascorbic acid following salvage chemotherapy for relapsed B-cell non-Hodgkin\u2019s lymphoma. Tokai J Exp Clin Med. 2014;39:111\u20135.","journal-title":"Tokai J Exp Clin Med"},{"issue":"222","key":"451_CR39","doi-asserted-by":"publisher","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","volume":"6","author":"Y Ma","year":"2014","unstructured":"Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014;6(222):222ra18. https:\/\/doi.org\/10.1126\/scitranslmed.3007154.","journal-title":"Sci Transl Med"},{"key":"451_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00280-013-2179-9","volume":"72","author":"CM Stephenson","year":"2013","unstructured":"Stephenson CM, Levin RD, Spector T, Lis CG. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol. 2013;72:139\u201346.","journal-title":"Cancer Chemother Pharmacol"},{"key":"451_CR41","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","volume":"71","author":"JL Welsh","year":"2013","unstructured":"Welsh JL, Wagner BA, van\u2019t Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol. 2013;71:765\u201375.","journal-title":"Cancer Chemother Pharmacol"},{"key":"451_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1479-5876-10-189","volume":"10","author":"N Mikirova","year":"2012","unstructured":"Mikirova N, Casciari J, Rogers A, Taylor P. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med. 2012;10:189. https:\/\/doi.org\/10.1186\/1479-5876-10-189.","journal-title":"J Transl Med"},{"key":"451_CR43","doi-asserted-by":"publisher","first-page":"e29794","DOI":"10.1371\/journal.pone.0029794","volume":"7","author":"DA Monti","year":"2012","unstructured":"Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, et al. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One. 2012;7:e29794. https:\/\/doi.org\/10.1371\/journal.pone.0029794.","journal-title":"PLoS ONE"},{"issue":"6","key":"451_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1600-0609.2009.01244.x","volume":"82","author":"JR Berenson","year":"2009","unstructured":"Berenson JR, Yellin O, Woytowitz D, Flam MS, Cartmell A, Patel R, et al. Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen. Eur J Haematol. 2009;82(6):433\u20139. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01244.x.","journal-title":"Eur J Haematol"},{"key":"451_CR45","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/annonc\/mdn377","volume":"19","author":"LJ Hoffer","year":"2008","unstructured":"Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, et al. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol. 2008;19:1969\u201374.","journal-title":"Ann Oncol"},{"key":"451_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3346\/jkms.2007.22.1.7","volume":"22","author":"CH Yeom","year":"2007","unstructured":"Yeom CH, Jung GC, Song KJ. Changes of terminal cancer patients\u2019 health-related quality of life after high dose vitamin C administration. J Korean Med Sci. 2007;22:7\u201311.","journal-title":"J Korean Med Sci"},{"key":"451_CR47","first-page":"269","volume":"24","author":"HD Riordan","year":"2005","unstructured":"Riordan HD, Casciari JJ, Gonz\u00e1lez MJ, Riordan NH, Miranda-Massari JR, Taylor P, et al. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J. 2005;24:269\u201376.","journal-title":"P R Health Sci J"},{"key":"451_CR48","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","volume":"92","author":"P Correa","year":"2000","unstructured":"Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000;92:1881\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"451_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM198501173120301","volume":"312","author":"CG Moertel","year":"1985","unstructured":"Moertel CG, Fleming TR, Creagan ET, Rubin J, O\u2019Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985;312:137\u201341.","journal-title":"N Engl J Med"},{"key":"451_CR50","first-page":"175","volume":"6","author":"JM Poulter","year":"1984","unstructured":"Poulter JM, White WF, Dickerson JW. Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta Vitaminol Enzymol. 1984;6:175\u201382.","journal-title":"Acta Vitaminol Enzymol"},{"key":"451_CR51","first-page":"103","volume":"23","author":"A Murata","year":"1982","unstructured":"Murata A, Morishige F, Yamaguchi H. Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int J Vitam Nutr Res Suppl. 1982;23:103\u201313.","journal-title":"Int J Vitam Nutr Res Suppl"},{"key":"451_CR52","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJM197909273011303","volume":"301","author":"ET Creagan","year":"1979","unstructured":"Creagan ET, Moertel CG, O\u2019Fallon JR, Schutt AJ, O\u2019Connell MJ, Rubin J, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. a controlled trial. N Engl J Med. 1979;301:687\u201390.","journal-title":"N Engl J Med"},{"issue":"9","key":"451_CR53","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1073\/pnas.75.9.4538","volume":"75","author":"E Cameron","year":"1978","unstructured":"Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1978;75(9):4538\u201342. https:\/\/doi.org\/10.1073\/pnas.75.9.4538.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"451_CR54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.phrs.2019.01.017","volume":"141","author":"CB Thomsen","year":"2019","unstructured":"Thomsen CB, Andersen RF, Steffensen KD, Adimi P, Jakobsen A. Delta tocotrienol in recurrent ovarian cancer. A phase II trial. Pharmacol Res. 2019;141:392\u20136.","journal-title":"Pharmacol Res"},{"key":"451_CR55","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.ebiom.2015.11.025","volume":"2","author":"GM Springett","year":"2015","unstructured":"Springett GM, Husain K, Neuger A, Centeno B, Chen DT, Hutchinson TZ, et al. A phase I safety, pharmacokinetic, and pharmacodynamic presurgical trial of vitamin E \u03b4-tocotrienol in patients with pancreatic ductal neoplasia. EBioMedicine. 2015;2:1987\u201395.","journal-title":"EBioMedicine"},{"key":"451_CR56","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/bcr2726","volume":"12","author":"K Nesaretnam","year":"2010","unstructured":"Nesaretnam K, Selvaduray KR, Abdul Razak G, Veerasenan SD, Gomez PA. Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial. Breast Cancer Res. 2010;12:R81. https:\/\/doi.org\/10.1186\/bcr2726.","journal-title":"Breast Cancer Res"},{"key":"451_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2008.864","volume":"301","author":"SM Lippman","year":"2009","unstructured":"Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39\u201351.","journal-title":"JAMA"},{"key":"451_CR58","first-page":"4701","volume":"48","author":"G McKeown-Eyssen","year":"1988","unstructured":"McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res. 1988;48:4701\u20135.","journal-title":"Cancer Res"},{"key":"451_CR59","doi-asserted-by":"publisher","first-page":"554","DOI":"10.18433\/J3ZG6R","volume":"17","author":"O Tabatabaei-Malazy","year":"2014","unstructured":"Tabatabaei-Malazy O, Nikfar S, Larijani B, Abdollahi M. Influence of ascorbic acid supplementation on type 2 diabetes mellitus in observational and randomized controlled trials; a systematic review with meta-analysis. J Pharm Pharm Sci. 2014;17:554\u201382.","journal-title":"J Pharm Pharm Sci"},{"key":"451_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12937-020-0520-9","volume":"19","author":"B Ghosn","year":"2020","unstructured":"Ghosn B, Benisi-Kohansal S, Ebrahimpour-Koujan S, Azadbakht L, Esmaillzadeh A. Association between healthy lifestyle score and breast cancer. Nutr J. 2020;19:4. https:\/\/doi.org\/10.1186\/s12937-020-0520-9.","journal-title":"Nutr J"},{"key":"451_CR61","first-page":"328","volume":"22","author":"B Zamani","year":"2019","unstructured":"Zamani B, Daneshzad E, Azadbakht L. Dietary total antioxidant capacity and risk of gastrointestinal cancers: a systematic review and meta-analysis of observational studies. Arch Iran Med. 2019;22:328\u201335.","journal-title":"Arch Iran Med"},{"key":"451_CR62","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/eci.12534","volume":"45","author":"M Khodaeian","year":"2015","unstructured":"Khodaeian M, Tabatabaei-Malazy O, Qorbani M, Farzadfar F, Amini P, Larijani B. Effect of vitamins C and E on insulin resistance in diabetes: a meta-analysis study. Eur J Clin Invest. 2015;45:1161\u201374.","journal-title":"Eur J Clin Invest"},{"key":"451_CR63","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fphys.2018.00809","volume":"9","author":"MCM Vissers","year":"2018","unstructured":"Vissers MCM, Das AB. Potential mechanisms of action for vitamin C in cancer: reviewing the evidence. Front Physiol. 2018;9:809. https:\/\/doi.org\/10.3389\/fphys.2018.00809.","journal-title":"Front Physiol"},{"key":"451_CR64","doi-asserted-by":"publisher","first-page":"9467","DOI":"10.7314\/APJCP.2014.15.21.9467","volume":"15","author":"T Nagamma","year":"2014","unstructured":"Nagamma T, Baxi J, Singh PP. Status of oxidative stress and antioxidant levels in smokers with breast cancer from western Nepal. Asian Pac J Cancer Prev. 2014;15:9467\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"key":"451_CR65","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2016.03.031","volume":"95","author":"L Rouleau","year":"2016","unstructured":"Rouleau L, Antony AN, Bisetto S, Newberg A, Doria C, Levine M, et al. Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity. Free Radic Biol Med. 2016;95:308\u201322.","journal-title":"Free Radic Biol Med"},{"key":"451_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejps.2017.05.038","volume":"105","author":"Y Yang","year":"2017","unstructured":"Yang Y, Lu X, Liu Q, Dai Y, Zhu X, Wen Y, et al. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Eur J Pharm Sci. 2017;105:219\u201329.","journal-title":"Eur J Pharm Sci"},{"key":"451_CR67","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1089\/ars.2013.5372","volume":"19","author":"NL Parrow","year":"2013","unstructured":"Parrow NL, Leshin JA, Levine M. Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Antioxid Redox Signal. 2013;19:2141\u201356.","journal-title":"Antioxid Redox Signal"},{"key":"451_CR68","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.freeradbiomed.2015.02.018","volume":"83","author":"JA Cieslak","year":"2015","unstructured":"Cieslak JA, Strother RK, Rawal M, Du J, Doskey CM, Schroeder SR, et al. Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer. Free Radic Biol Med. 2015;83:227\u201337.","journal-title":"Free Radic Biol Med"},{"key":"451_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ebiom.2017.02.011","volume":"18","author":"J Xia","year":"2017","unstructured":"Xia J, Xu H, Zhang X, Allamargot C, Coleman KL, Nessler R, et al. Multiple myeloma tumor cells are selectively killed by pharmacologically-dosed ascorbic acid. EBioMedicine. 2017;18:41\u20139.","journal-title":"EBioMedicine"},{"key":"451_CR70","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.freeradbiomed.2011.03.007","volume":"50","author":"MG Espey","year":"2011","unstructured":"Espey MG, Chen P, Chalmers B, Drisko J, Sun AY, Levine M, et al. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med. 2011;50:1610\u20139.","journal-title":"Free Radic Biol Med"},{"key":"451_CR71","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fphys.2018.01182","volume":"9","author":"AC Carr","year":"2018","unstructured":"Carr AC, Cook J. Intravenous vitamin C for cancer therapy-identifying the current gaps in our knowledge. Front Physiol. 2018;9:1182. https:\/\/doi.org\/10.3389\/fphys.2018.01182.","journal-title":"Front Physiol"},{"key":"451_CR72","first-page":"443","volume":"1826","author":"J Du","year":"2012","unstructured":"Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 2012;1826:443\u201357.","journal-title":"Biochim Biophys Acta"},{"key":"451_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bcmd.2013.05.003","volume":"51","author":"XY Cui","year":"2013","unstructured":"Cui XY, Skretting G, Jing Y, Sun H, Sandset PM, Sun L. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells. Blood Cells Mol Dis. 2013;51:177\u201384.","journal-title":"Blood Cells Mol Dis"},{"key":"451_CR74","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3945\/an.117.016329","volume":"8","author":"Q Jiang","year":"2017","unstructured":"Jiang Q. Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy. Adv Nutr. 2017;8:850\u201367.","journal-title":"Adv Nutr"},{"key":"451_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(12)70477-1","volume":"14","author":"J Bennouna","year":"2013","unstructured":"Bennouna J, Sastre J, Arnold D, \u00d6sterlund P, Greil R, Van Cutsem E, et al. ML18147 Study Investigators. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. Lancet Oncol. 2013;14:29\u201337.","journal-title":"Lancet Oncol"},{"key":"451_CR76","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphar.2011.00004","volume":"2","author":"SW Gratz","year":"2011","unstructured":"Gratz SW, Wallace RJ, El-Nezami HS. Recent perspectives on the relations between fecal mutagenicity, genotoxicity, and diet. Front Pharmacol. 2011;2:4. https:\/\/doi.org\/10.3389\/fphar.2011.00004.","journal-title":"Front Pharmacol"},{"key":"451_CR77","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00535-012-0691-z","volume":"48","author":"L Bonelli","year":"2013","unstructured":"Bonelli L, Puntoni M, Gatteschi B, Massa P, Missale G, Munizzi F, et al. Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial. J Gastroenterol. 2013;48:698\u2013705.","journal-title":"J Gastroenterol"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-022-00451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-022-00451-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-022-00451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:22:53Z","timestamp":1669908173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-022-00451-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s40199-022-00451-x","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study was approved by the Ethics Committee of Vice-Chancellor in Research Affairs-Tehran University of Medical Sciences (IR.TUMS.VCR.REC.1397.926).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}